Alexandria Real Estate Equities-backed gene-edited seed developer Cibus has withdrawn its IPO application three months after setting a price range that would have raised $107m at the upper end.

Cibus, a US-based plant-breeding technology developer backed by life sciences real estate manager Alexandra Real Estate Equities, has withdrawn its proposed initial public offering. The company did not offer a reason for its decision. It filed for an offering on the Nasdaq Global Select Market in November 2018 and planned to issue approximately 6.67 million…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.